『The Science of APOE4: Why Evolution Kept the Alzheimer's Gene』のカバーアート

The Science of APOE4: Why Evolution Kept the Alzheimer's Gene

The Science of APOE4: Why Evolution Kept the Alzheimer's Gene

無料で聴く

ポッドキャストの詳細を見る
Every year more people get their DNA tested, and a lot of them find out they carry a gene called APOE4, the so called Alzheimer's gene. Today Dr. Ravi Kumar takes it apart, because he carries a copy himself, and the standard story about it never quite added up to him.Ravi builds the case with real data. In the Tsimane of the Bolivian Amazon, a 2017 study of 372 people found something backwards from what you'd expect: APOE4 carriers with a heavy parasite burden held onto their cognition while non-carriers declined, and a separate study of nearly 800 Tsimane women found carriers had more children, born earlier and spaced closer together. The gene also runs a quieter baseline immune system that fires harder the moment a real threat shows up, which was useful when infection, not old age, was the thing most likely to kill you.None of that makes APOE4 harmless today. The famous odds ratio of 14.9 doesn't mean two copies makes someone 15 times more likely to get Alzheimer's, the number that actually applies to your life is lifetime risk, which by 85 runs around 51 percent for men and 60 percent for women with two copies. Nearly everyone with two copies develops the amyloid and tau pathology under the microscope, yet roughly four in ten still reach 85 with a clear mind. Ravi carries one copy himself, and the standard message about it, honestly, never sat right with him. His answer isn't to dismiss the risk, it's to reframe it: two copies raises your risk substantially, but it does not decide your outcome.The rest of the episode is what to actually do with that reframe: protecting deep sleep, since even one lost night has been shown to raise amyloid in the brain, treating hearing loss, which is one of the few dementia interventions backed by a randomized trial instead of just correlation, and guarding insulin sensitivity and blood pressure specifically in your 40s and 50s, the exact window where the data shows the damage compounding.What You'll LearnAPOE4 Is The Ancestral Version: Comparing human DNA to chimpanzee DNA shows the chimp version of the gene lines up closest with APOE4, which suggests E3 and E2 are the newer variants and E4 is the original form our lineage carried.Odds Ratio Is Not Lifetime Risk: The widely cited 14.9 odds ratio from a 1997 JAMA meta-analysis does not mean two copies makes you 15 times more likely to develop Alzheimer's, the number that actually maps onto your life is lifetime risk.Four In Ten Reach 85 Untouched: Even with two copies of APOE4, roughly four in ten men and four in ten women reach age 85 without ever developing Alzheimer's disease.Pathology Is Not Dementia: Nearly every person with two copies of APOE4 develops the amyloid plaques and tau tangles visible on brain scans, yet about half of them still reach 85 with a clear, strong mind.The Parasite Flip In The Tsimane: A 2017 study of 372 Tsimane found APOE4 carriers without much parasite exposure recalled fewer words than non-carriers, but among those with a heavy parasite burden the pattern flipped and APOE4 carriers held their cognition while non-carriers declined.APOE4 And More Children: A 2023 study of 795 Tsimane women found carrying APOE4 was linked to more children, earlier first births, and shorter gaps between pregnancies.The Smoke Detector Immune System: In the Tsimane, APOE4 carriers ran about 30 percent lower baseline inflammation but mounted a stronger immune response the moment a real threat appeared, quiet until there's an actual fire.Hearing Aids Cut Cognitive Decline: The randomized ACHIEVE trial, published in The Lancet in 2023, found hearing aids cut the rate of cognitive decline roughly in half among older adults already at higher risk, one of the few dementia interventions backed by a controlled trial rather than an association.One Night Of Lost Sleep Raises Amyloid: A 2018 study that kept 20 healthy adults awake for a single night found amyloid rose about 5 percent in the thalamus and hippocampus, the areas the glymphatic system is supposed to be clearing while you sleep.Diabetes Plus APOE4 Multiplies Risk: A 2002 study found that having type 2 diabetes on top of carrying APOE4 raised relative risk 5.5 times compared with having neither, making insulin sensitivity one of the clearest gene-environment interactions in the literature.Selection Had No Leverage At 80: Among the Hadza hunter-gatherers, only about 8 of every 100 births reached age 80, so a gene that only causes harm that late in life was nearly invisible to natural selection while its fertility and infection benefits acted on everyone.Midlife Blood Pressure Doubles Risk: A 2001 BMJ study following nearly 1,500 people for decades found high blood pressure in your 40s and 50s roughly doubled later Alzheimer's risk, and high midlife cholesterol on top of it more than tripled the risk.Episode Highlights:[00:00:00] Would evolution really keep a bad gene?[00:02:14] Why Ravi is making this episode[00:04:19] Disclaimer and what APOE actually is[00:...
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません